Banka BioLoo Limited (NSE:BANKA)
India · Delayed Price · Currency is INR 59.80
-0.49 (-0.81%)
Feb 19, 2026, 3:28 PM IST
Banka BioLoo Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 542.53 | 541.74 | 499.96 | 423.5 | 387.51 | 304.58 |
Other Revenue | -0 | - | -0 | - | - | - |
| 542.53 | 541.74 | 499.96 | 423.5 | 387.51 | 304.58 | |
Revenue Growth (YoY) | -2.51% | 8.36% | 18.05% | 9.29% | 27.23% | -36.37% |
Cost of Revenue | 430.75 | 453.24 | 403.04 | 293.34 | 246.27 | 169.32 |
Gross Profit | 111.78 | 88.5 | 96.92 | 130.15 | 141.24 | 135.25 |
Selling, General & Admin | 69.63 | 57.97 | 36.21 | 4.14 | 4.05 | 9.07 |
Other Operating Expenses | 25.84 | 59.21 | 23.29 | 65.6 | 81.47 | 92.1 |
Operating Expenses | 123.24 | 142.48 | 81.39 | 84.57 | 94.93 | 107.15 |
Operating Income | -11.46 | -53.98 | 15.54 | 45.59 | 46.31 | 28.11 |
Interest Expense | -33.79 | -33.82 | -22.76 | -15 | -16.41 | -14.65 |
Interest & Investment Income | 2.51 | 2.51 | 3.78 | 5.56 | 3.91 | - |
Earnings From Equity Investments | 0.6 | 0.28 | -0.21 | 0.06 | 0.27 | -0.02 |
Currency Exchange Gain (Loss) | 0.62 | 0.62 | - | - | - | -0.02 |
Other Non Operating Income (Expenses) | 4.72 | -3.74 | -1.99 | 0.03 | -0.97 | 5.27 |
EBT Excluding Unusual Items | -36.81 | -88.13 | -5.63 | 36.24 | 33.11 | 18.68 |
Impairment of Goodwill | -3.15 | -3.15 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.04 | 0.04 | - | - | -0.03 | - |
Other Unusual Items | 3.15 | - | - | - | - | - |
Pretax Income | -36.77 | -91.24 | -5.63 | 36.24 | 33.08 | 18.68 |
Income Tax Expense | -8.5 | -2.15 | 1.08 | 10.85 | 2.01 | -3.36 |
Earnings From Continuing Operations | -28.27 | -89.09 | -6.71 | 25.39 | 31.08 | 22.05 |
Minority Interest in Earnings | -0.27 | -0.06 | 0.19 | - | - | -0 |
Net Income | -28.53 | -89.15 | -6.53 | 25.39 | 31.08 | 22.05 |
Net Income to Common | -28.53 | -89.15 | -6.53 | 25.39 | 31.08 | 22.05 |
Net Income Growth | - | - | - | -18.30% | 40.95% | -64.59% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 10 | 10 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 10 | 10 |
Shares Change (YoY) | 1.06% | -1.00% | 1.67% | 4.85% | 0.18% | - |
EPS (Basic) | -2.63 | -8.22 | -0.60 | 2.35 | 3.02 | 2.14 |
EPS (Diluted) | -2.63 | -8.22 | -0.60 | 2.34 | 3.02 | 2.14 |
EPS Growth | - | - | - | -22.44% | 40.98% | -64.67% |
Free Cash Flow | - | -36.13 | -72.07 | 9.4 | -36 | 53.55 |
Free Cash Flow Per Share | - | -3.32 | -6.56 | 0.87 | -3.50 | 5.21 |
Gross Margin | 20.60% | 16.34% | 19.39% | 30.73% | 36.45% | 44.41% |
Operating Margin | -2.11% | -9.96% | 3.11% | 10.76% | 11.95% | 9.23% |
Profit Margin | -5.26% | -16.46% | -1.31% | 6.00% | 8.02% | 7.24% |
Free Cash Flow Margin | - | -6.67% | -14.41% | 2.22% | -9.29% | 17.58% |
EBITDA | 10.72 | -34.37 | 31.72 | 54.74 | 51.93 | 33.38 |
EBITDA Margin | 1.98% | -6.35% | 6.35% | 12.93% | 13.40% | 10.96% |
D&A For EBITDA | 22.18 | 19.61 | 16.19 | 9.15 | 5.62 | 5.27 |
EBIT | -11.46 | -53.98 | 15.54 | 45.59 | 46.31 | 28.11 |
EBIT Margin | -2.11% | -9.96% | 3.11% | 10.76% | 11.95% | 9.23% |
Effective Tax Rate | - | - | - | 29.94% | 6.07% | - |
Revenue as Reported | 554.27 | 545.01 | 504.91 | 430.51 | 392.05 | 310.34 |
Advertising Expenses | - | 0.57 | 0.51 | 1.94 | 0.3 | 0.98 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.